Global Asthma Reliever (Rescue) Medications Market Research Report 2023

Publisher Name :
Date: 24-Jan-2023
No. of pages: 93
Inquire Before Buying

Highlights

The global Asthma Reliever (Rescue) Medications market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Asthma Reliever (Rescue) Medications is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Asthma Reliever (Rescue) Medications is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Asthma Reliever (Rescue) Medications include Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals,Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc and Sepracor, Inc, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Asthma Reliever (Rescue) Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Reliever (Rescue) Medications.

The Asthma Reliever (Rescue) Medications market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Asthma Reliever (Rescue) Medications market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Asthma Reliever (Rescue) Medications manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Dulera

- QVAR

- Glaxosmithkline plc

- MAP Pharmaceuticals,Inc

- Merck & Co. Inc

- AstraZeneca plc

- Roche Holdings Ltd

- Genentech Inc

- Sepracor, Inc

- Schering-Plough Corp

- Sanofi-Aventis

- Theravance Inc

Segment by Type

- Quick-Relief Medications

- Long-Term Control Medications

Segment by Application

- Children

- Adolescent

- Adult

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Asthma Reliever (Rescue) Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Asthma Reliever (Rescue) Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global Asthma Reliever (Rescue) Medications Market Research Report 2023

Table of Contents
1 Asthma Reliever (Rescue) Medications Market Overview
1.1 Product Overview and Scope of Asthma Reliever (Rescue) Medications
1.2 Asthma Reliever (Rescue) Medications Segment by Type
1.2.1 Global Asthma Reliever (Rescue) Medications Market Value Comparison by Type (2023-2029)
1.2.2 Quick-Relief Medications
1.2.3 Long-Term Control Medications
1.3 Asthma Reliever (Rescue) Medications Segment by Application
1.3.1 Global Asthma Reliever (Rescue) Medications Market Value by Application: (2023-2029)
1.3.2 Children
1.3.3 Adolescent
1.3.4 Adult
1.4 Global Asthma Reliever (Rescue) Medications Market Size Estimates and Forecasts
1.4.1 Global Asthma Reliever (Rescue) Medications Revenue 2018-2029
1.4.2 Global Asthma Reliever (Rescue) Medications Sales 2018-2029
1.4.3 Global Asthma Reliever (Rescue) Medications Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Asthma Reliever (Rescue) Medications Market Competition by Manufacturers
2.1 Global Asthma Reliever (Rescue) Medications Sales Market Share by Manufacturers (2018-2023)
2.2 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Asthma Reliever (Rescue) Medications Average Price by Manufacturers (2018-2023)
2.4 Global Asthma Reliever (Rescue) Medications Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Asthma Reliever (Rescue) Medications, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma Reliever (Rescue) Medications, Product Type & Application
2.7 Asthma Reliever (Rescue) Medications Market Competitive Situation and Trends
2.7.1 Asthma Reliever (Rescue) Medications Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Asthma Reliever (Rescue) Medications Players Market Share by Revenue
2.7.3 Global Asthma Reliever (Rescue) Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Asthma Reliever (Rescue) Medications Retrospective Market Scenario by Region
3.1 Global Asthma Reliever (Rescue) Medications Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Asthma Reliever (Rescue) Medications Global Asthma Reliever (Rescue) Medications Sales by Region: 2018-2029
3.2.1 Global Asthma Reliever (Rescue) Medications Sales by Region: 2018-2023
3.2.2 Global Asthma Reliever (Rescue) Medications Sales by Region: 2024-2029
3.3 Global Asthma Reliever (Rescue) Medications Global Asthma Reliever (Rescue) Medications Revenue by Region: 2018-2029
3.3.1 Global Asthma Reliever (Rescue) Medications Revenue by Region: 2018-2023
3.3.2 Global Asthma Reliever (Rescue) Medications Revenue by Region: 2024-2029
3.4 North America Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
3.4.1 North America Asthma Reliever (Rescue) Medications Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Asthma Reliever (Rescue) Medications Sales by Country (2018-2029)
3.4.3 North America Asthma Reliever (Rescue) Medications Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
3.5.1 Europe Asthma Reliever (Rescue) Medications Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Asthma Reliever (Rescue) Medications Sales by Country (2018-2029)
3.5.3 Europe Asthma Reliever (Rescue) Medications Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
3.6.1 Asia Pacific Asthma Reliever (Rescue) Medications Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Asthma Reliever (Rescue) Medications Sales by Country (2018-2029)
3.6.3 Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
3.7.1 Latin America Asthma Reliever (Rescue) Medications Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Asthma Reliever (Rescue) Medications Sales by Country (2018-2029)
3.7.3 Latin America Asthma Reliever (Rescue) Medications Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Asthma Reliever (Rescue) Medications Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma Reliever (Rescue) Medications Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Asthma Reliever (Rescue) Medications Sales by Country (2018-2029)
3.8.3 Middle East and Africa Asthma Reliever (Rescue) Medications Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Asthma Reliever (Rescue) Medications Sales by Type (2018-2029)
4.1.1 Global Asthma Reliever (Rescue) Medications Sales by Type (2018-2023)
4.1.2 Global Asthma Reliever (Rescue) Medications Sales by Type (2024-2029)
4.1.3 Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2018-2029)
4.2 Global Asthma Reliever (Rescue) Medications Revenue by Type (2018-2029)
4.2.1 Global Asthma Reliever (Rescue) Medications Revenue by Type (2018-2023)
4.2.2 Global Asthma Reliever (Rescue) Medications Revenue by Type (2024-2029)
4.2.3 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2018-2029)
4.3 Global Asthma Reliever (Rescue) Medications Price by Type (2018-2029)
5 Segment by Application
5.1 Global Asthma Reliever (Rescue) Medications Sales by Application (2018-2029)
5.1.1 Global Asthma Reliever (Rescue) Medications Sales by Application (2018-2023)
5.1.2 Global Asthma Reliever (Rescue) Medications Sales by Application (2024-2029)
5.1.3 Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2018-2029)
5.2 Global Asthma Reliever (Rescue) Medications Revenue by Application (2018-2029)
5.2.1 Global Asthma Reliever (Rescue) Medications Revenue by Application (2018-2023)
5.2.2 Global Asthma Reliever (Rescue) Medications Revenue by Application (2024-2029)
5.2.3 Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2018-2029)
5.3 Global Asthma Reliever (Rescue) Medications Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Dulera
6.1.1 Dulera Corporation Information
6.1.2 Dulera Description and Business Overview
6.1.3 Dulera Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Dulera Asthma Reliever (Rescue) Medications Product Portfolio
6.1.5 Dulera Recent Developments/Updates
6.2 QVAR
6.2.1 QVAR Corporation Information
6.2.2 QVAR Description and Business Overview
6.2.3 QVAR Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.2.4 QVAR Asthma Reliever (Rescue) Medications Product Portfolio
6.2.5 QVAR Recent Developments/Updates
6.3 Glaxosmithkline plc
6.3.1 Glaxosmithkline plc Corporation Information
6.3.2 Glaxosmithkline plc Description and Business Overview
6.3.3 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product Portfolio
6.3.5 Glaxosmithkline plc Recent Developments/Updates
6.4 MAP Pharmaceuticals?Inc
6.4.1 MAP Pharmaceuticals?Inc Corporation Information
6.4.2 MAP Pharmaceuticals?Inc Description and Business Overview
6.4.3 MAP Pharmaceuticals?Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.4.4 MAP Pharmaceuticals?Inc Asthma Reliever (Rescue) Medications Product Portfolio
6.4.5 MAP Pharmaceuticals?Inc Recent Developments/Updates
6.5 Merck & Co. Inc
6.5.1 Merck & Co. Inc Corporation Information
6.5.2 Merck & Co. Inc Description and Business Overview
6.5.3 Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck & Co. Inc Asthma Reliever (Rescue) Medications Product Portfolio
6.5.5 Merck & Co. Inc Recent Developments/Updates
6.6 AstraZeneca plc
6.6.1 AstraZeneca plc Corporation Information
6.6.2 AstraZeneca plc Description and Business Overview
6.6.3 AstraZeneca plc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AstraZeneca plc Asthma Reliever (Rescue) Medications Product Portfolio
6.6.5 AstraZeneca plc Recent Developments/Updates
6.7 Roche Holdings Ltd
6.6.1 Roche Holdings Ltd Corporation Information
6.6.2 Roche Holdings Ltd Description and Business Overview
6.6.3 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product Portfolio
6.7.5 Roche Holdings Ltd Recent Developments/Updates
6.8 Genentech Inc
6.8.1 Genentech Inc Corporation Information
6.8.2 Genentech Inc Description and Business Overview
6.8.3 Genentech Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Genentech Inc Asthma Reliever (Rescue) Medications Product Portfolio
6.8.5 Genentech Inc Recent Developments/Updates
6.9 Sepracor, Inc
6.9.1 Sepracor, Inc Corporation Information
6.9.2 Sepracor, Inc Description and Business Overview
6.9.3 Sepracor, Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Sepracor, Inc Asthma Reliever (Rescue) Medications Product Portfolio
6.9.5 Sepracor, Inc Recent Developments/Updates
6.10 Schering-Plough Corp
6.10.1 Schering-Plough Corp Corporation Information
6.10.2 Schering-Plough Corp Description and Business Overview
6.10.3 Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Schering-Plough Corp Asthma Reliever (Rescue) Medications Product Portfolio
6.10.5 Schering-Plough Corp Recent Developments/Updates
6.11 Sanofi-Aventis
6.11.1 Sanofi-Aventis Corporation Information
6.11.2 Sanofi-Aventis Asthma Reliever (Rescue) Medications Description and Business Overview
6.11.3 Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sanofi-Aventis Asthma Reliever (Rescue) Medications Product Portfolio
6.11.5 Sanofi-Aventis Recent Developments/Updates
6.12 Theravance Inc
6.12.1 Theravance Inc Corporation Information
6.12.2 Theravance Inc Asthma Reliever (Rescue) Medications Description and Business Overview
6.12.3 Theravance Inc Asthma Reliever (Rescue) Medications Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Theravance Inc Asthma Reliever (Rescue) Medications Product Portfolio
6.12.5 Theravance Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma Reliever (Rescue) Medications Industry Chain Analysis
7.2 Asthma Reliever (Rescue) Medications Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma Reliever (Rescue) Medications Production Mode & Process
7.4 Asthma Reliever (Rescue) Medications Sales and Marketing
7.4.1 Asthma Reliever (Rescue) Medications Sales Channels
7.4.2 Asthma Reliever (Rescue) Medications Distributors
7.5 Asthma Reliever (Rescue) Medications Customers
8 Asthma Reliever (Rescue) Medications Market Dynamics
8.1 Asthma Reliever (Rescue) Medications Industry Trends
8.2 Asthma Reliever (Rescue) Medications Market Drivers
8.3 Asthma Reliever (Rescue) Medications Market Challenges
8.4 Asthma Reliever (Rescue) Medications Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Asthma Reliever (Rescue) Medications Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Asthma Reliever (Rescue) Medications Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Asthma Reliever (Rescue) Medications Market Competitive Situation by Manufacturers in 2022
Table 4. Global Asthma Reliever (Rescue) Medications Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Asthma Reliever (Rescue) Medications Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Asthma Reliever (Rescue) Medications Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Asthma Reliever (Rescue) Medications Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Asthma Reliever (Rescue) Medications Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Asthma Reliever (Rescue) Medications, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Asthma Reliever (Rescue) Medications, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Asthma Reliever (Rescue) Medications, Product Type & Application
Table 12. Global Key Manufacturers of Asthma Reliever (Rescue) Medications, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Asthma Reliever (Rescue) Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Asthma Reliever (Rescue) Medications as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Asthma Reliever (Rescue) Medications Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Asthma Reliever (Rescue) Medications Sales by Region (2018-2023) & (K Units)
Table 18. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2018-2023)
Table 19. Global Asthma Reliever (Rescue) Medications Sales by Region (2024-2029) & (K Units)
Table 20. Global Asthma Reliever (Rescue) Medications Sales Market Share by Region (2024-2029)
Table 21. Global Asthma Reliever (Rescue) Medications Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2018-2023)
Table 23. Global Asthma Reliever (Rescue) Medications Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2024-2029)
Table 25. North America Asthma Reliever (Rescue) Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Asthma Reliever (Rescue) Medications Sales by Country (2018-2023) & (K Units)
Table 27. North America Asthma Reliever (Rescue) Medications Sales by Country (2024-2029) & (K Units)
Table 28. North America Asthma Reliever (Rescue) Medications Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Asthma Reliever (Rescue) Medications Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Asthma Reliever (Rescue) Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Asthma Reliever (Rescue) Medications Sales by Country (2018-2023) & (K Units)
Table 32. Europe Asthma Reliever (Rescue) Medications Sales by Country (2024-2029) & (K Units)
Table 33. Europe Asthma Reliever (Rescue) Medications Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Asthma Reliever (Rescue) Medications Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Asthma Reliever (Rescue) Medications Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Asthma Reliever (Rescue) Medications Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Asthma Reliever (Rescue) Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Asthma Reliever (Rescue) Medications Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Asthma Reliever (Rescue) Medications Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Asthma Reliever (Rescue) Medications Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Asthma Reliever (Rescue) Medications Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Asthma Reliever (Rescue) Medications Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Asthma Reliever (Rescue) Medications Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Asthma Reliever (Rescue) Medications Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Asthma Reliever (Rescue) Medications Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Asthma Reliever (Rescue) Medications Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Asthma Reliever (Rescue) Medications Sales (K Units) by Type (2018-2023)
Table 51. Global Asthma Reliever (Rescue) Medications Sales (K Units) by Type (2024-2029)
Table 52. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2018-2023)
Table 53. Global Asthma Reliever (Rescue) Medications Sales Market Share by Type (2024-2029)
Table 54. Global Asthma Reliever (Rescue) Medications Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Asthma Reliever (Rescue) Medications Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2018-2023)
Table 57. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Type (2024-2029)
Table 58. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Type (2018-2023)
Table 59. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Type (2024-2029)
Table 60. Global Asthma Reliever (Rescue) Medications Sales (K Units) by Application (2018-2023)
Table 61. Global Asthma Reliever (Rescue) Medications Sales (K Units) by Application (2024-2029)
Table 62. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2018-2023)
Table 63. Global Asthma Reliever (Rescue) Medications Sales Market Share by Application (2024-2029)
Table 64. Global Asthma Reliever (Rescue) Medications Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Asthma Reliever (Rescue) Medications Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2018-2023)
Table 67. Global Asthma Reliever (Rescue) Medications Revenue Market Share by Application (2024-2029)
Table 68. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Application (2018-2023)
Table 69. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Application (2024-2029)
Table 70. Dulera Corporation Information
Table 71. Dulera Description and Business Overview
Table 72. Dulera Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Dulera Asthma Reliever (Rescue) Medications Product
Table 74. Dulera Recent Developments/Updates
Table 75. QVAR Corporation Information
Table 76. QVAR Description and Business Overview
Table 77. QVAR Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. QVAR Asthma Reliever (Rescue) Medications Product
Table 79. QVAR Recent Developments/Updates
Table 80. Glaxosmithkline plc Corporation Information
Table 81. Glaxosmithkline plc Description and Business Overview
Table 82. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Glaxosmithkline plc Asthma Reliever (Rescue) Medications Product
Table 84. Glaxosmithkline plc Recent Developments/Updates
Table 85. MAP Pharmaceuticals?Inc Corporation Information
Table 86. MAP Pharmaceuticals?Inc Description and Business Overview
Table 87. MAP Pharmaceuticals?Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. MAP Pharmaceuticals?Inc Asthma Reliever (Rescue) Medications Product
Table 89. MAP Pharmaceuticals?Inc Recent Developments/Updates
Table 90. Merck & Co. Inc Corporation Information
Table 91. Merck & Co. Inc Description and Business Overview
Table 92. Merck & Co. Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Merck & Co. Inc Asthma Reliever (Rescue) Medications Product
Table 94. Merck & Co. Inc Recent Developments/Updates
Table 95. AstraZeneca plc Corporation Information
Table 96. AstraZeneca plc Description and Business Overview
Table 97. AstraZeneca plc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. AstraZeneca plc Asthma Reliever (Rescue) Medications Product
Table 99. AstraZeneca plc Recent Developments/Updates
Table 100. Roche Holdings Ltd Corporation Information
Table 101. Roche Holdings Ltd Description and Business Overview
Table 102. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Roche Holdings Ltd Asthma Reliever (Rescue) Medications Product
Table 104. Roche Holdings Ltd Recent Developments/Updates
Table 105. Genentech Inc Corporation Information
Table 106. Genentech Inc Description and Business Overview
Table 107. Genentech Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Genentech Inc Asthma Reliever (Rescue) Medications Product
Table 109. Genentech Inc Recent Developments/Updates
Table 110. Sepracor, Inc Corporation Information
Table 111. Sepracor, Inc Description and Business Overview
Table 112. Sepracor, Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Sepracor, Inc Asthma Reliever (Rescue) Medications Product
Table 114. Sepracor, Inc Recent Developments/Updates
Table 115. Schering-Plough Corp Corporation Information
Table 116. Schering-Plough Corp Description and Business Overview
Table 117. Schering-Plough Corp Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Schering-Plough Corp Asthma Reliever (Rescue) Medications Product
Table 119. Schering-Plough Corp Recent Developments/Updates
Table 120. Sanofi-Aventis Corporation Information
Table 121. Sanofi-Aventis Description and Business Overview
Table 122. Sanofi-Aventis Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Sanofi-Aventis Asthma Reliever (Rescue) Medications Product
Table 124. Sanofi-Aventis Recent Developments/Updates
Table 125. Theravance Inc Corporation Information
Table 126. Theravance Inc Description and Business Overview
Table 127. Theravance Inc Asthma Reliever (Rescue) Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Theravance Inc Asthma Reliever (Rescue) Medications Product
Table 129. Theravance Inc Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Asthma Reliever (Rescue) Medications Distributors List
Table 133. Asthma Reliever (Rescue) Medications Customers List
Table 134. Asthma Reliever (Rescue) Medications Market Trends
Table 135. Asthma Reliever (Rescue) Medications Market Drivers
Table 136. Asthma Reliever (Rescue) Medications Market Challenges
Table 137. Asthma Reliever (Rescue) Medications Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Asthma Reliever (Rescue) Medications
Figure 2. Global Asthma Reliever (Rescue) Medications Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Asthma Reliever (Rescue) Medications Market Share by Type in 2022 & 2029
Figure 4. Quick-Relief Medications Product Picture
Figure 5. Long-Term Control Medications Product Picture
Figure 6. Global Asthma Reliever (Rescue) Medications Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Asthma Reliever (Rescue) Medications Market Share by Application in 2022 & 2029
Figure 8. Children
Figure 9. Adolescent
Figure 10. Adult
Figure 11. Global Asthma Reliever (Rescue) Medications Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Asthma Reliever (Rescue) Medications Market Size (2018-2029) & (US$ Million)
Figure 13. Global Asthma Reliever (Rescue) Medications Sales (2018-2029) & (K Units)
Figure 14. Global Asthma Reliever (Rescue) Medications Average Price (US$/Unit) & (2018-2029)
Figure 15. Asthma Reliever (Rescue) Medications Report Years Considered
Figure 16. Asthma Reliever (Rescue) Medications Sales Share by Manufacturers in 2022
Figure 17. Global Asthma Reliever (Rescue) Medications Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Asthma Reliever (Rescue) Medications Players: Market Share by Revenue in 2022
Figure 19. Asthma Reliever (Rescue) Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Asthma Reliever (Rescue) Medications Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Asthma Reliever (Rescue) Medications Sales Market Share by Country (2018-2029)
Figure 22. North America Asthma Reliever (Rescue) Medications Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Asthma Reliever (Rescue) Medications Sales Market Share by Country (2018-2029)
Figure 26. Europe Asthma Reliever (Rescue) Medications Revenue Market Share by Country (2018-2029)
Figure 27. Germany Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Asthma Reliever (Rescue) Medications Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Asthma Reliever (Rescue) Medications Revenue Market Share by Region (2018-2029)
Figure 34. China Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Taiwan Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Asthma Reliever (Rescue) Medications Sales Market Share by Country (2018-2029)
Figure 45. Latin America Asthma Reliever (Rescue) Medications Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Asthma Reliever (Rescue) Medications Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Asthma Reliever (Rescue) Medications Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Asthma Reliever (Rescue) Medications Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Asthma Reliever (Rescue) Medications by Type (2018-2029)
Figure 55. Global Revenue Market Share of Asthma Reliever (Rescue) Medications by Type (2018-2029)
Figure 56. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Asthma Reliever (Rescue) Medications by Application (2018-2029)
Figure 58. Global Revenue Market Share of Asthma Reliever (Rescue) Medications by Application (2018-2029)
Figure 59. Global Asthma Reliever (Rescue) Medications Price (US$/Unit) by Application (2018-2029)
Figure 60. Asthma Reliever (Rescue) Medications Value Chain
Figure 61. Asthma Reliever (Rescue) Medications Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
  • Global Ejiao Health Products Market Research Report 2023
    Published: 26-Jan-2023        Price: US 2900 Onwards        Pages: 89
    Highlights The global Ejiao Health Products market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North American market for Ejiao Health Products is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Protein Inhibitors Market Research Report 2023
    Published: 26-Jan-2023        Price: US 2900 Onwards        Pages: 99
    Highlights The global Protein Inhibitors market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Protein Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Prescription Pain Medications Market Research Report 2023
    Published: 26-Jan-2023        Price: US 2900 Onwards        Pages: 97
    Highlights The global Prescription Pain Medications market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Prescription Pain Medications is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2......
  • Global Recombinant Coagulation Factor IX Market Research Report 2023
    Published: 26-Jan-2023        Price: US 2900 Onwards        Pages: 94
    Highlights The global Recombinant Coagulation Factor IX market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Recombinant Coagulation Factor IX is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast per......
  • Global Guselkumab Injection Market Research Report 2023
    Published: 26-Jan-2023        Price: US 2900 Onwards        Pages: 71
    Highlights The global Guselkumab Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Guselkumab Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Microporous Polysaccharide Hemospheres (MPH) Market Research Report 2023
    Published: 26-Jan-2023        Price: US 2900 Onwards        Pages: 69
    Highlights The global Microporous Polysaccharide Hemospheres (MPH) market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Microporous Polysaccharide Hemospheres (MPH) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % d......
  • Global Oral COVID-19 Drug Market Research Report 2023
    Published: 26-Jan-2023        Price: US 2900 Onwards        Pages: 66
    Highlights The global Oral COVID-19 Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Oral COVID-19 Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Adjunctive Hemostats Market Research Report 2023
    Published: 26-Jan-2023        Price: US 2900 Onwards        Pages: 70
    Highlights The global Adjunctive Hemostats market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Adjunctive Hemostats is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.......
  • Global Ceftazidime Avibactam Market Research Report 2023
    Published: 26-Jan-2023        Price: US 2900 Onwards        Pages: 74
    Highlights The global Ceftazidime Avibactam market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. North American market for Ceftazidime Avibactam is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs